What Ketamine Treatment Costs in Pennsylvania
In Pennsylvania, a single IV ketamine session typically costs $350 to $500 out of pocket. A standard first course is six sessions, so roughly $2,100 to $3,000. Spravato works differently — it is usually billed through insurance, and most insured patients pay far less. As of 18 Jul 2026.
What will this cost me in Pennsylvania?
Answer a few questions and we will show a range — or tell you plainly when we cannot give you a number worth having. Nothing you choose is sent anywhere, and there is nothing to sign up for.
How we work this out
For off-label ketamine — infusions, injections and lozenges — we take the published price band for Pennsylvania and multiply by the number of sessions in the course you picked. Coverage does not change that figure, because these are not FDA-approved for depression and are almost never covered.
For Spravato we start from the drug's list price and a typical administration fee, then apply the rules of your coverage type — Medicare's 20% coinsurance, a commercial plan's coinsurance widened by whether your deductible is met, or the manufacturer's per-dose figure where the savings card applies.
Where we cannot be honest, we do not give a number. Medicare Advantage copays, Medicaid approvals, VA referral pathways and self-pay Spravato prices all vary more than any estimate could capture, so we say so and tell you who can answer instead.
Every figure is rounded outward — per session to the nearest $25, course totals to the nearest $100 — so that nothing here can be mistaken for a quote. Ranges are never narrower than about 1.4 times the lower bound, because a tight range would imply a confidence we do not have.
Our biggest known weakness: Spravato's list price is not published by the manufacturer or in any free public source. The figure we start from is a reported launch price from 2019 and is very likely low. That is why Spravato estimates are labelled rough, and why we refuse to produce a self-pay Spravato figure at all.
Think one of our numbers is wrong? We would rather know. Tell us and we will date the correction.
Based on published pricing and coverage rules as of 2019-03-05. Sources for every figure this tool can show:
Only esketamine (Spravato) is FDA-approved to treat depression. Racemic ketamine given by IV, injection, or under the tongue has no FDA approval for any psychiatric condition and is used off-label — that is, an approved drug used for an unapproved purpose. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 1, opens in a new tab)
Under Original Medicare Part B in 2026 you pay a $283 yearly deductible first, and after that you generally pay 20% of the Medicare-approved amount for covered services. as of 1 Jan 2026 · Centers for Medicare and Medicaid Services (source 2, opens in a new tab)Deductible and premium amounts are set annually and change each January.
Pennsylvania Medical Assistance covers Spravato, but lists it as a non-preferred medicine on the statewide preferred drug list, which means prior approval is required before your plan will pay. The same rules apply whether you are in fee-for-service or a managed care plan. as of 1 Jan 2026 · Pennsylvania Department of Human Services (source 3, opens in a new tab)
In Pennsylvania an intramuscular ketamine injection costs around $400 at clinics that provide the injection alone, rising to roughly $650 to $1,400 a session at practices where a therapist stays with you for the whole two to three hours. as of 18 Jul 2026 · Published Pennsylvania clinic price lists (source 4, opens in a new tab)The wide spread is real: it reflects whether you are paying for an injection or for several hours of a clinician's time.
Pennsylvania clinics that publish their prices charge roughly $350 to $500 for a single IV ketamine infusion, with a six-session starting course commonly priced at around $2,100 to $2,500. as of 18 Jul 2026 · Published Pennsylvania clinic price lists (source 5, opens in a new tab)Based on five Pennsylvania clinics that publish prices. Most do not, and the clinic sets the price — treat this as a guide to what a reasonable answer sounds like, not as a quote.
Sublingual ketamine lozenges themselves are inexpensive in Pennsylvania, at roughly $75 to $200 for a prescription. Supervised lozenge sessions are billed separately by clinician time, at roughly $500 to $1,250 a session. as of 18 Jul 2026 · Published Pennsylvania clinic price lists (source 6, opens in a new tab)These are two different things and quotes often conflate them. Ask whether a price covers the medicine, the supervised session, or both.
Best available information: No Pennsylvania clinic we could find publishes a self-pay price for Spravato. National figures suggest roughly $850 to $1,600 a session covering both the medicine and the required two-hour monitoring, but we have no Pennsylvania figure we would stand behind. as of 5 May 2026 · HealingMaps (source 7, opens in a new tab)This is a national figure from one secondary directory, not a Pennsylvania price. Our estimator does not produce a self-pay Spravato number from it, because it is not good enough evidence to build a figure on.
The FDA approved Spravato (esketamine) nasal spray on 5 March 2019, for use with an oral antidepressant, for adults with treatment-resistant depression. as of 5 Mar 2019 · U.S. Food and Drug Administration (source 8, opens in a new tab)
Spravato is available only through a restricted safety programme called a Risk Evaluation and Mitigation Strategy (REMS), and may only be given in a certified healthcare setting under a provider's direct observation. Patients never take it home. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 10, opens in a new tab)
Best available information: Spravato's list price is not published by the manufacturer or in any free public source. At launch in 2019 the wholesale acquisition cost was around $590 for a 56 mg dose and $885 for an 84 mg dose, and the current list price is very likely higher. as of 5 Mar 2019 · Drugs.com (source 11, opens in a new tab)Wholesale acquisition cost is published only in paywalled pricing compendia. The figures here are seven years old and come from a secondary source, so we do not use them to produce a dollar estimate — the estimator suppresses Spravato cash figures rather than presenting a number this weak.
The Spravato withMe savings programme is not available to anyone using a state or federal government health programme, including Medicare, Medicaid, TRICARE, the Department of Defense, and the Veterans Administration. as of 18 Jul 2026 · Johnson & Johnson (source 13, opens in a new tab)
Through the Spravato withMe savings programme, eligible patients with commercial insurance may pay as little as $10 per treatment for the medicine itself, subject to yearly maximum benefits and quantity limits. as of 18 Jul 2026 · Johnson & Johnson (source 14, opens in a new tab)The programme covers the medicine, not the office visit or the two-hour observation, which is often the larger share of the bill. The official terms state that a yearly maximum applies but do not publish the amount, so we do not either. Terms are set per calendar year.
Why the range is so wide
Clinics set their own prices and few publish them. These are the things that actually move the number, and every one of them is a fair question to ask before you book.
- Whether the clinic bills insurance at all, or is cash-only.
- Whether an anaesthesiologist or nurse anaesthetist is present for the infusion.
- Where in Pennsylvania you are — metro clinics generally charge more than rural ones.
- Whether the clinic sells prepaid packages, which lower the per-session price but tie up your money.
- Whether the first psychiatric evaluation is included or billed separately.
- Whether the two-hour observation after Spravato is a separate charge.
IV ketamine: the cash-pay reality
Only esketamine (Spravato) is FDA-approved to treat depression. Racemic ketamine given by IV, injection, or under the tongue has no FDA approval for any psychiatric condition and is used off-label — that is, an approved drug used for an unapproved purpose. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 1, opens in a new tab)
Because it is off-label, IV ketamine is essentially never covered by insurance — so for most people the price above is what they will actually pay, in full, themselves.
UnitedHealthcare's national policy states that ketamine injection is investigational, and therefore not proven or medically necessary, for psychiatric conditions including depression, bipolar disorder and post-traumatic stress disorder. This is the clearest published statement of why commercial insurance rarely pays for IV ketamine. as of 1 May 2026 · UnitedHealthcare (source 2, opens in a new tab)This describes one commercial insurer. It does not describe any state Medicaid programme, none of which publishes criteria for racemic ketamine either way.
Many clinics offer packages at a lower price per session. Those packages are usually prepaid, which is a real risk: if the treatment does not suit you, or you cannot tolerate it, you may have paid for sessions you will not use. Ask what happens to the balance before you pay.
Spravato: the insurance route
The FDA approved Spravato (esketamine) nasal spray on 5 March 2019, for use with an oral antidepressant, for adults with treatment-resistant depression. as of 5 Mar 2019 · U.S. Food and Drug Administration (source 2, opens in a new tab)
On 17 January 2025 the FDA approved Spravato for treatment-resistant depression in adults either on its own or together with an oral antidepressant, so a companion oral antidepressant is now optional for this use — though it is still permitted. as of 17 Jan 2025 · U.S. Food and Drug Administration (source 3, opens in a new tab)This applies to the treatment-resistant depression indication only. The separate indication for major depressive disorder with acute suicidal ideation still requires an oral antidepressant — see spravato.approval_mdd_si. Widely-cited secondary sources give 21 January 2025; that is the manufacturer's announcement date, not the FDA action date on the approval letter.
Because Spravato is FDA-approved, it can be billed to insurance — which makes your coverage, not the clinic's list price, the main thing determining what you pay. We go through coverage in Pennsylvania in detail, including what your prescriber has to document and what to do if you are turned down.
The four ways ketamine is given, compared
| Treatment | Typical cash cost | FDA status | Where and how long | Typical course | Insurance | Driving |
|---|---|---|---|---|---|---|
| IV ketamine infusion | $350–$500 | Not FDA-approved for depression (off-label) | In a clinic, usually 40–60 minutes plus recovery | Typically six sessions over two to three weeks | Almost never covered | You will need someone to drive you home |
| Spravato (esketamine) | Depends on your coverage | FDA-approved for treatment-resistant depression | Self-administered nasal spray in a certified clinic, with two hours of monitoring | Twice weekly for four weeks, then less often | Usually billed through insurance, with prior approval | No driving until the next day, after a night of restful sleep |
| IM injection | $400–$1,400 | Not FDA-approved for depression (off-label) | In a clinic, shorter than an infusion | Varies by clinic | Almost never covered | You will need someone to drive you home |
| Sublingual or lozenge | $500–$1,250 | Not FDA-approved for depression (off-label) | At home, or in a supervised session | Varies widely by programme | Almost never covered | Do not drive after a dose |
Only esketamine (Spravato) is FDA-approved to treat depression. Racemic ketamine given by IV, injection, or under the tongue has no FDA approval for any psychiatric condition and is used off-label — that is, an approved drug used for an unapproved purpose. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 1, opens in a new tab)
Pennsylvania clinics that publish their prices charge roughly $350 to $500 for a single IV ketamine infusion, with a six-session starting course commonly priced at around $2,100 to $2,500. as of 18 Jul 2026 · Published Pennsylvania clinic price lists (source 5, opens in a new tab)Based on five Pennsylvania clinics that publish prices. Most do not, and the clinic sets the price — treat this as a guide to what a reasonable answer sounds like, not as a quote.
In Pennsylvania an intramuscular ketamine injection costs around $400 at clinics that provide the injection alone, rising to roughly $650 to $1,400 a session at practices where a therapist stays with you for the whole two to three hours. as of 18 Jul 2026 · Published Pennsylvania clinic price lists (source 4, opens in a new tab)The wide spread is real: it reflects whether you are paying for an injection or for several hours of a clinician's time.
Sublingual ketamine lozenges themselves are inexpensive in Pennsylvania, at roughly $75 to $200 for a prescription. Supervised lozenge sessions are billed separately by clinician time, at roughly $500 to $1,250 a session. as of 18 Jul 2026 · Published Pennsylvania clinic price lists (source 6, opens in a new tab)These are two different things and quotes often conflate them. Ask whether a price covers the medicine, the supervised session, or both.
After a Spravato dose you must not drive or operate machinery until the next day, following a restful night's sleep, so you need to arrange a ride home from every session. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 10, opens in a new tab)
Questions that get you a real number
Prices are set by the clinic, not by us. These are the questions that turn a vague quote into a figure you can plan around. Print this page or write them down before you call.
- What is the total price for a full initial course, not just one session?
- Is the first psychiatric evaluation included, or billed separately?
- Is the two-hour observation after Spravato billed as a separate charge?
- Do you bill my insurance directly, or do I pay and claim it back myself?
- If I stop partway through a prepaid package, what happens to the balance?
- Who is in the room during treatment, and what are their qualifications?
- What happens if my blood pressure rises during a session?
- Are you certified in the Spravato REMS programme?
Once you have a number, the clinician list shows who is registered in Pennsylvania — and what we have and have not been able to confirm about them.